Gamma Investing LLC Eye Point Pharmaceuticals, Inc. Transaction History
Gamma Investing LLC
- $1.17 Trillion
- Q4 2024
A detailed history of Gamma Investing LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 313 shares of EYPT stock, worth $2,419. This represents 0.0% of its overall portfolio holdings.
Number of Shares
313
Previous 106
195.28%
Holding current value
$2,419
Previous $847,000
175.32%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EYPT
# of Institutions
154Shares Held
58.2MCall Options Held
177KPut Options Held
263K-
Cormorant Asset Management, LP Boston, MA8.33MShares$64.4 Million4.66% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$40 Million1.63% of portfolio
-
Franklin Resources Inc San Mateo, CA4.01MShares$31 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.79MShares$29.3 Million0.06% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$29.1 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $263M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...